Q2 revenue $4.9M (+18% YoY), net loss $20.3M; 365-day Eversense Q4 launch on track

Senseonics Holdings, Inc.

2024-Q2 EPS reported -$0.06 revenue$9,912,000

Q2 2024 revenue $4.9M, up 18% vs $4.1M in Q2 2023; U.S. revenue $3.0M (+67%), OUS $1.9M.
Net loss $20.3M ($0.03/sh) vs $20.4M ($0.04/sh); gross profit slipped to $0.3M from $0.4M.
FY 2024 revenue guidance unchanged at $22M-$24M; cash burn expected ~$70M, in line with 2023.
FDA 510(k) review ongoing for 365-day Eversense; planned Q4 launch; Gemini System first-in-human testing began.
Eon Care Services subsidiary formed; Mercy collaboration RPM service initial insertions expected Q3 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.